Showing results (741-750 of 1,351) with videos related to
Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|July 13, 2021
Bioequivalence Evaluation Between Acarbose and Metformin Fixed-Dose Combination and Corresponding Individual Components in Healthy Chinese Male and Female SubjectsChao Liu, Adriaan Cleton, Yubin Sui, et al.Clinical Pharmacology in Drug Development|July 15, 2021
Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study ParticipantsRajendra P Singh, Kimberly Adkison, Allen Wolstenholme, et al.Clinical Pharmacology in Drug Development|December 5, 2020
Pharmacokinetics and Safety of Fosaprepitant Dimeglumine in Healthy Chinese Volunteers: Bioequivalence StudyKang Lu, Sisi Lin, Yannan Wang, et al.Clinical Pharmacology in Drug Development|December 22, 2020
Safety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose StudySrividya Neelakantan, Barry Oemar, Kristen Johnson, et al.Clinical Pharmacology in Drug Development|May 6, 2022
Pharmacokinetics and Bioequivalence of Single-Oral-Dose Linagliptin: A Randomized, 2-Period Crossover Trial in Chinese Healthy Subjects Under Fasting and Fed ConditionsYan Li, Xueyuan Zhang, Lu Qi, et al.Clinical Pharmacology in Drug Development|July 31, 2021
Update on ICH E14/S7B Cardiac Safety Regulations: The Expanded Role of Preclinical Assays and the "Double-Negative" ScenarioRobert M LesterClinical Pharmacology in Drug Development|September 22, 2018
Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal FunctionMichael A Tortorici, Danielle Duffy, Rebecca Evans, et al.Clinical Pharmacology in Drug Development|September 27, 2018
Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous InfusionBrett E Houk, Christine W Alvey, Ravi Visswanathan, et al.Clinical Pharmacology in Drug Development|September 20, 2018
Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy VolunteersNaoki Kotani, Koichiro Yoneyama, Nobuhiko Kawakami, et al.Clinical Pharmacology in Drug Development|April 13, 2019
Absolute Oral Bioavailability of Glasdegib (PF-04449913), a Smoothened Inhibitor, in Randomized Healthy VolunteersNaveed Shaik, Brian Hee, Yali Liang, et al.Pageof 136